By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


Company News
Partnership and Acquisition Rumors in the CAR-T Cancer Space Finger Juno (JUNO), Kite Pharma (KITE) and bluebird bio (BLUE) 7/16/2015 6:23:27 AM
Kite Pharma (KITE) And The Leukemia & Lymphoma Society Enter Into Collaboration To Enhance The Development Of KTE-C19 In Refractory Aggressive Non-Hodgkin Lymphoma And Launch CAR T-Cell Therapy Educational Programs 7/1/2015 7:11:35 AM
Kite Pharma (KITE), bluebird bio (BLUE) Ink Deal to Zero In on HPV-Linked Cancer 6/22/2015 6:53:32 AM
Kite Pharma (KITE) To Host Investor Day On June 23, 2015 6/16/2015 8:06:47 AM
H. Lee Moffitt Cancer Center & Research Institute Announces First Patient In Nation Treated With KTE-C19 In Kite Pharma (KITE)'s Clinical Trial For Non-Hodgkin's Lymphoma 6/2/2015 1:59:21 PM
ASCO15: Kite Pharma (KITE) Presents Clinical Biomarker Results in Patients Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy at the 2015 ASCO Annual Meeting 6/2/2015 10:49:25 AM
Kite Pharma (KITE) To Present Clinical Biomarkers From Patients Treated With Anti-CD19 Chimeric Antigen Receptor T Cell Therapy At The 2015 ASCO Annual Meeting 5/29/2015 9:03:17 AM
Kite Pharma (KITE) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/26/2015 7:02:37 AM
Kite Pharma (KITE) Announces That The First Patient In Its Phase I/II Clinical Trial Has Been Treated With KTE-C19, Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, For Refractory Aggressive Non-Hodgkin's Lymphoma (NHL) 5/21/2015 11:05:37 AM
Kite Pharma (KITE) Reports First Quarter 2015 Financial Results 5/17/2015 4:48:25 PM